Literature DB >> 17719542

hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.

Tomoaki Tanaka1, Shuichi Ohkubo, Ichiro Tatsuno, Carol Prives.   

Abstract

The p53 tumor suppressor protein regulates many genes that can determine different cellular outcomes such as growth arrest or cell death. Promoter-selective transactivation by p53, although critical for the different cellular outcomes, is not well understood. We report here that the human cellular apoptosis susceptibility protein (hCAS/CSE1L) associates with a subset of p53 target promoters, including PIG3, in a p53-autonomous manner. Downregulation of hCAS/CSE1L decreases transcription from those p53 target promoters to which it preferentially binds and reduces apoptosis. In addition, hCAS/CSE1L silencing leads to increased methylation of histone H3 lysine 27 within the PIG3 gene. hCAS/CSE1L was previously shown to function as a nucleo-cytoplasmic transport factor, as does its closely related yeast homologue Cse1, which can also associate with chromatin and serve as a barrier protein that prevents spreading of heterochromatin. Thus, human CAS/CSE1L can bind select genes with significant functional consequences for p53-mediated transcription and determine cellular outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719542     DOI: 10.1016/j.cell.2007.08.001

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  93 in total

1.  Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD.

Authors:  Amrita Cheema; Chad D Knights; Mahadev Rao; Jason Catania; Ricardo Perez; Brigitte Simons; Sivanesan Dakshanamurthy; Vamsi K Kolukula; Maddalena Tilli; Priscilla A Furth; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1.

Authors:  Yingjuan Qian; Yong-Sam Jung; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-21       Impact factor: 11.205

3.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

4.  Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

5.  Mechanisms of regulatory diversity within the p53 transcriptional network.

Authors:  J M Espinosa
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

Review 6.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

7.  A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells.

Authors:  Kyoung-Hwa Lee; Mangmang Li; Aleksandra M Michalowski; Xinyue Zhang; Hongling Liao; Lingyi Chen; Yang Xu; Xiaolin Wu; Jing Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 8.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

Review 9.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

10.  Rap2b, a novel p53 target, regulates p53-mediated pro-survival function.

Authors:  Xinyue Zhang; Yunlong He; Kyoung-Hwa Lee; Wendy Dubois; Ziqing Li; Xiaolin Wu; Alexander Kovalchuk; Weimin Zhang; Jing Huang
Journal:  Cell Cycle       Date:  2013-03-27       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.